Track the CLEARPOINT NEURO INC stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €474.3m. The latest transaction was disclosed on 29 June 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: JOSEPH BURNETT. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
CLEARPOINT NEURO INC is a company focused on developing surgical navigation technologies for the treatment of neurological disorders. It aims to improve clinical outcomes through innovative solutions.